Blueprint Medicines Corp (BPMC) — Cash Flow Quality Index
Blueprint Medicines Corp (BPMC) has a Cash Flow Quality Index of -109.84x as of March 2025. Operating cash flow of $-54.48 Million is below net income of $496.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Blueprint Medicines Corp to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Blueprint Medicines Corp Cash Flow Quality Index (2020–2020)
Historical Cash Flow Quality Index for Blueprint Medicines Corp across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BPMC goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Blueprint Medicines Corp (2020–2020)
Year-by-year earnings quality comparison for Blueprint Medicines Corp. For live market cap and the full company financial profile, see how much is Blueprint Medicines Corp worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.23x | $387.04 Million | $313.88 Million | — |